class = “cf”>
A new study has been conducted on the coronavirus (Kovid-19), which has been part of our lives for about 2 years.
British experts have revealed that a cholesterol drug currently in use causes early recovery in patients with covid-19.
Because, according to information from the British Mirror newspaper, the drug has shown that fenofibrate and its active form, acid fenofibrate, can “significantly” reduce Kovid-19 infection in human cells.
According to research conducted by scientists at the University of Birmingham and Keele University in England and the San Raffaele Institute of Science in Italy, the drug in question can reduce coronavirus infection by up to 70%. %.
In the statement made by the team, he said that this drug has been shown to be equally effective against the newer variants of Kovid-19, including the Alpha and Beta variants.
It was pointed out that research on the effectiveness of the drug against the recently dominant Delta variant is continuing.
class = “cf”>
Scientists have called for a clinical trial to test the drug on coronavirus patients in UK hospitals.
Dr Farhat Khanim of the University of Birmingham made the following statements about his work;
The emergence of new, more contagious variants of SARS-CoV-2 has caused rapid increases in infection rates and deaths in many countries around the world, particularly in the UK and US. While vaccination programs will hopefully reduce infection rates and the spread of the virus in the long term, there is an urgent need to expand our arsenal of drugs to treat SARS-CoV-2 positive patients.
The drug is currently licensed for use in the UK to treat high levels of cholesterol and fatty substances (lipids) in the blood.
Scientists are now requesting the extension of this license.
This guide guides gastronomy enthusiasts